Transformed follicular lymphoma (tFL): consolidation therapy may improve survival
ConclusionThis consecutively treated series of 26 patients with tFL have had a better outcome than expected which may be due to the use of rituximab-chemotherapy and a consolidation strategy based on age, PS and availability of a sibling donor.
Source: Irish Journal of Medical Science - Category: Journals (General) Source Type: research
More News: Biomedical Science | Burkitt Lymphoma | Chemotherapy | Databases & Libraries | General Medicine | Lymphoma | Rituxan | Science | Stem Cell Therapy | Stem Cells | Study | Transplants